Is INO or INSM more undervalued in 2026?

CirclFi compares Inovio Pharmaceuticals, Inc. (INO) and Insmed Incorporated (INSM) using 13 institutional-grade valuation models. INO has a Quality of Company score of 4.3/10 while INSM scores 4.0/10.

Which is a better buy — INO or INSM?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do INO and INSM valuations compare?

INO at $1.30 and INSM at $108.37 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

INO vs INSM Valuation Comparison 2026 — Intrinsic Value Analysis

INO

Biotechnology

Inovio Pharmaceuticals, Inc.

Quality

4.3

out of 10

Value Trap

WARN

Price

$1.30

Last close

Models

8/13

Active

INSM

Biotechnology

Insmed Incorporated

Quality

4.0

out of 10

Value Trap

SAFE

Price

$108.37

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	INO Fair Value	INO Upside	INSM Fair Value	INSM Upside
Bayesian DCF	Intrinsic	$0.48	-63.1%	$36.85	-66.0%
Earnings Power Value	Intrinsic	—	—	$64.56	-52.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$2.08	+60.0%	$2.67	-97.5%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for INO vs INSM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

INO vs INSM — Which Stock Is More Undervalued?

INO scores higher with a 4.3/10 quality rating vs INSM's 4.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Inovio Pharmaceuticals, Inc. (INO) and Insmed Incorporated (INSM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

INO currently trades at $1.30 with a QOC of 4.3/10, while INSM trades at $108.37 with a QOC of 4.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).